Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Raises Additional $1.2M in Debt Placement

NEW YORK (GenomeWeb News) – GeneNews today said that it has raised an additional C$1,475,210 (US$1.2 million) through the third tranche of a private placement of debentures.

The total amount of debentures sold to date in the offering is C$3,252,342. GeneNews said that more than one quarter of the debentures were purchased by members of management and the board of directors.

The Toronto-based firm said that proceeds from the placement would be used for general working capital purposes and continued marketing of its ColonSentry test in Canada, as well as for pre-launch activities for the test in the US and Asia.

GeneNews said that it has accepted subscriptions for five-year, 15 percent redeemable convertible secured debentures. The 15 percent annual interest will be paid upon the earlier of maturity, conversion, or redemption of the debentures.

Each purchaser of a debenture will also receive one warrant for every C$.25 of principal amount of their debenture. Each of those warrants is exercisable into GeneNews common shares for a period of 36 months following the date of issuance at a price of C$.25 per common share.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.